biote Corp. (BTMD) stock
BTMDNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/3065% below fair value
$0.89−0.10 (-10.51%)
Close on Nov 18, 2026Market cap $31.83MP/E 8.9Yield –
biote shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
biote's shares outstanding was 29M at Jun 30, 2026. For fiscal 2025 it was 37M, up 7.0% from the year before.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 37M | +7.0% |
| FY2024 | Dec 31, 2024 | 34M | +33.3% |
| FY2023 | Dec 31, 2023 | 26M | +219.0% |
| FY2022 | Dec 31, 2022 | 8M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 29M | -9.8% |
| Q1 FY2026 | Mar 31, 2026 | 36M | -2.6% |
| Q4 FY2025 | Dec 31, 2025 | 36M | -3.6% |
| Q3 FY2025 | Sep 30, 2025 | 37M | +13.8% |
| Q2 FY2025 | Jun 30, 2025 | 32M | -4.0% |
| Q1 FY2025 | Mar 31, 2025 | 37M | +6.7% |
| Q4 FY2024 | Dec 31, 2024 | 37M | +9.7% |
| Q3 FY2024 | Sep 30, 2024 | 32M | +3.9% |
| Q2 FY2024 | Jun 30, 2024 | 33M | +59.7% |
| Q1 FY2024 | Mar 31, 2024 | 35M | +96.9% |
| Q4 FY2023 | Dec 31, 2023 | 34M | +260.6% |
| Q3 FY2023 | Sep 30, 2023 | 31M | +308.2% |
| Q2 FY2023 | Jun 30, 2023 | 21M | +173.4% |
| Q1 FY2023 | Mar 31, 2023 | 18M | – |
| Q4 FY2022 | Dec 31, 2022 | 9M | – |
| Q3 FY2022 | Sep 30, 2022 | 8M | – |
| Q2 FY2022 | Jun 30, 2022 | 8M | – |
See a number that looks wrong?